AstraZeneca: IMFINZI improved event-free survival, OS across MIBC

Published on 15 Feb 2025 on TipRanks · via Yahoo Finance

Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed...

Read the rest of the article

Start tracking your investments with Statfolio

(Bloomberg) -- GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with k...

Bloomberg · via Yahoo Finance 21 Feb 2025

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this...

Insider Monkey · via Yahoo Finance 20 Feb 2025

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quart...

Insider Monkey · via Yahoo Finance 20 Feb 2025

Anglo American PLC climbed after signalling another write down for its De Beers diamond unit in...

Investing.com 20 Feb 2025

AstraZeneca PLC (LON:AZN) announced a healthy earnings result recently, and the market rewarded i...

Simply Wall St. · via Yahoo Finance 18 Feb 2025

Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed...

TipRanks · via Yahoo Finance 15 Feb 2025

U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.46%

Investing.com 14 Feb 2025

We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. ...

Insider Monkey · via Yahoo Finance 14 Feb 2025

Sweden stocks lower at close of trade; OMX Stockholm 30 down 0.27%

Investing.com 14 Feb 2025

Hedge fund Citadel has made a 305 million pound ($384.5 million) bet against drugmaker GSK , the...

Reuters 14 Feb 2025